title: Rituximab intolerance in patients with Waldenström macroglobulinaemia.
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA. jorgej_castillo@dfci.harvard.edu.|Harvard Medical School, Boston, MA, USA. jorgej_castillo@dfci.harvard.edu.
authors.forename: Jorge J
authors.initials: JJ
authors.lastname: Castillo
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Sandra
authors.initials: S
authors.lastname: Kanan
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Meid
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Manning
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Zachary R
authors.initials: ZR
authors.lastname: Hunter
authors.affiliation: Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.|Harvard Medical School, Boston, MA, USA.
authors.forename: Steven P
authors.initials: SP
authors.lastname: Treon
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab / Q000494:pharmacology*; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
chemical_list: D000069283:Rituximab
keywords: Lymphoplasmacytic lymphoma; Waldenstrom macroglobulinaemia; infusion; rituximab